#2 - Thermo Fisher Scientific (NYSE:TMO)
Thermo Fisher Scientific Inc. (NYSE: TMO) is an American supplier of scientific instrumentation, reagents, consumables, and software services for the medical industry. This is a favorable position for the company to be in with the incoming Trump administration’s America First agenda, which includes less regulation.
TMO stock is down approximately 1.2% in 2024. Much of that is due to the company’s revenue from China, which has been flat over the last year. However, TMO stock has been a savvy long-term investment among medical stocks, with a 62.33% total return in the last five years. And when you zoom out over a longer period, the total return is even more impressive.
With a stock price of over $550 per share as of December 23, 2024, investors should look past the yield of just 0.30%, which is below the average yield for medical stocks. However, the company has increased its dividend for seven consecutive years, the annualized three-year growth rate is 16.7%, and it has a very sustainable payout ratio of around 9.7%.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Read More - Current Price
- $528.98
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 17 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $650.05 (22.9% Upside)
